Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / COM
-
Number of holders
-
56
-
Total 13F shares, excl. options
-
9.41M
-
Shares change
-
+2.21M
-
Total reported value, excl. options
-
$68.2M
-
Value change
-
+$7.06M
-
Put/Call ratio
-
0.39
-
Number of buys
-
41
-
Number of sells
-
-12
-
Price
-
$7.25
Significant Holders of Humacyte, Inc. - COM (HUMA) as of Q4 2021
72 filings reported holding HUMA - Humacyte, Inc. - COM as of Q4 2021.
Humacyte, Inc. - COM (HUMA) has 56 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.41M shares
.
Largest 10 shareholders include York Capital Management Global Advisors, LLC (2.29M shares), BlackRock Inc. (1.4M shares), VANGUARD GROUP INC (1.17M shares), UBS OCONNOR LLC (900K shares), GEODE CAPITAL MANAGEMENT, LLC (604K shares), Monashee Investment Management LLC (400K shares), Diameter Capital Partners LP (300K shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (294K shares), Gladstone Institutional Advisory LLC (247K shares), and UBS Group AG (241K shares).
This table shows the top 56 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.